Initial fund targets medical devices, digital solutions, and diagnostics Olympus Corporation (Tokyo: 7733), a global leader in medical technology, has…
Browsing: BioTech
Revenue jumps 62% to S$152.3 million for 9M2021, and 48% to S$57.7 million for 3Q2021 Rewards shareholders with proposed interim…
Family cord blood bank Cryoviva Singapore is pleased to announce that it has now been accredited by the Association of…
Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma…
The company is raising USD$25 million from investors in Australia, Asia and USA. Topelia Australia, a biotech company established to…
Malaysians will soon be able to order healthier breads and food products from Starbucks Malaysia, Kenny Rogers and 7-Eleven stores…
ForQaly Medical (hereinafter referred to as ForQaly), located in Shanghai Zhangjiang International Medical Zone, is a leading high-tech company focused…
Ikervis(R) (ciclosporin), a new, once-daily treatment for severe keratitis (keh-ruh-tai-tis) in adults with dry eye disease (DED) which has not…
POWERSEAL Family of Devices Completes the Olympus Energy Portfolio, Offers Physicians Improved Performance and Ergonomics Olympus Corporation (Representative Executive Officer,…
On September 13, 2021, Hua Medicine (Shanghai) Ltd. (the Hua Medicine, HKG: 2552) has signed a supply chain strategic cooperation…
Legend Capital led a new round of investment of PT Etana Biotechnologies Indonesia (Etana), along with Innovent Biologics, Inc. (Innovent)…
Recently, Berry Oncology, a company focusing on genomic testing of cancers in China, announced the completion of a US$99.15 million…
Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been…
Local family cord blood bank Cryoviva Singapore (https://cryoviva.com.sg) is continuing with its rapid geographic growth plans with an entry into…
Kintor Pharmaceutical Limited (Kintor Pharma, HKG: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced…
New Horizon Health (HKG:6606) (the Company), the first public listed cancer screening company in China, has today announced its financial…
New Drug Application for a potential First in Class GKA dorzagliatin accepted by NMPA Expansion of indications for dorzagliatin strengthened…
On June 10, 2021, the National Health Commission issued the notice “Distributing the Special Rectification Work Plan for Combating Illegal…
Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific…
China Biotech Services Holdings Limited (CH BIOTECH SER or Company, HKG:8037) is pleased to announce that Asia Molecular Diagnostic Laboratory…